<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38212779</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Evaluation of 17 years of MERIN (Meningitis and Encephalitis register in Lower Saxony, Germany) surveillance system: participants acceptability survey, completeness and timeliness of data.</ArticleTitle><Pagination><StartPage>59</StartPage><MedlinePgn>59</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">59</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-023-10482-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A Meningitis and Encephalitis Surveillance (MERIN) was implemented in 2003 in Lower Saxony, Germany as an alternative to acute flaccid paralyses surveillance, as the latter did not reach WHO sensitivity criteria. The system provides information on circulating enterovirus (EV) serotypes by focussing on patients with suspected aseptic meningitis, encephalitis or acute flaccid paralysis and contributes to the national surveillance in documenting polio free status. MERIN is based on voluntary participation of hospitals. Therefore, our evaluation focusses on acceptability of the system's objectives and performance, and identifying areas for improvement.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To assess acceptability, 32 contributing hospitals were invited to an online-based survey (11/2021 to 01/2022) to rate the MERIN objectives, laboratory's performance, their workload, modes of processes and communication. Ideas for improvement were collected in open fields. In addition, data completeness and timeliness of laboratory diagnostics were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 32 hospitals, 21 responded (66% response rate), sending 30 questionnaires, 25 from pediatric and 5 from neurological departments. High levels of satisfaction with the communication (≥ 96%), timeliness (≥ 81%), and distribution of the results (≥ 85%) were reported, 97% of participants judged the required workload as adequate. The median proportion of eligible patients included in MERIN was 75%. Participants gave rapid and reliable diagnostic testing the highest priority (96%), while monitoring of Germany's polio-free status was rated the lowest (61%). Providing medical reports digitally as well as regular updates about circulating EV serotypes were identified as areas for improvement. Data completeness of selected variables ranged from 78.3 to 99.9%. Median time between sample collection and arrival at laboratory was 2 days [IQR 1-3], EV diagnostics via PCR took one day [IQR 0-6] and EV isolation on cell culture 11 days [IQR 10-13].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MERIN is a highly accepted surveillance system. Its quality was enhanced further by addressing the suggested improvements such as regular reports on circulating EV serotypes and facilitating digital access to laboratory results. Our results emphasise the importance of recognizing and considering participants' motivations and expectations, and addressing their priorities, even if this is not the surveillance system's main focus. This approach can be applied to surveillance systems of other non-mandatory notifiable diseases.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Łuczyńska</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Centre for Disease Control and Prevention (ECDC), ECDC Fellowship Programme, Field Epidemiology Path (EPIET), Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyrer</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holle</LastName><ForeName>Ina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baillot</LastName><ForeName>Armin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monazahian</LastName><ForeName>Masyar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreesman</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mertens</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rettenbacher-Riefler</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department for Microbiology, Infection Protection, Hospital Hygiene and Epidemiology of Infectious Diseases, Public Health Agency of Lower Saxony, Hanover, Lower Saxony, Germany. sophie.rettenbacher-riefler@nlga.niedersachsen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008581" MajorTopicYN="Y">Meningitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Evaluation</Keyword><Keyword MajorTopicYN="N">Meningitis</Keyword><Keyword MajorTopicYN="N">Polio-eradication</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38212779</ArticleId><ArticleId IdType="pmc">PMC10782521</ArticleId><ArticleId IdType="doi">10.1186/s12913-023-10482-y</ArticleId><ArticleId IdType="pii">10.1186/s12913-023-10482-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Polio Surveillance Action Plan 2022–2024. Geneva: World Health Organization; 2022. https://iris.awho.int/bitstream/handle/10665/354479/9789240047310-eng.pdf?sequence=1.</Citation></Reference><Reference><Citation>Umeh GC, Shuaib F, Musa A, Tegegne SG, Braka F, Mkanda P, et al. Acute flaccid paralysis (AFP) surveillance intensification for polio certification in Kaduna state, Nigeria: lessons learnt, 2015–2016. BMC Public Health. 2018;18:1310. doi: 10.1186/s12889-018-6186-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-018-6186-y</ArticleId><ArticleId IdType="pmc">PMC6291918</ArticleId><ArticleId IdType="pubmed">30541509</ArticleId></ArticleIdList></Reference><Reference><Citation>Enterovirus surveillance guidelines . Guidelines for enterovirus surveillance in support of the polio eradication initiative. Copenhagen: World Health Organization, Regional Office for Europe; 2015.</Citation></Reference><Reference><Citation>Masa-Calles J, Torner N, López-Perea N, Torres de Mier MdV, Fernández-Martínez B, Cabrerizo M, et al. Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years’ experience, Spain, 1998 to 2015. Euro Surveill. 2018. 10.2807/1560-7917.ES.2018.23.47.1700423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341937</ArticleId><ArticleId IdType="pubmed">30482263</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeren K, Böttcher S, Diedrich S. Enterovirus Surveillance (EVSurv) in Germany. Microorganisms. 2021 doi: 10.3390/microorganisms9102005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9102005</ArticleId><ArticleId IdType="pmc">PMC8538599</ArticleId><ArticleId IdType="pubmed">34683328</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich S, Beyrer K. Bundesweite Enterovirus-Surveillance im Rahmen der Polioeradikation: Ergebnisse aus den ersten vier Projektjahren. 2010. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2010/Ausgaben/01_10.pdf?__blob=publicationFile.</Citation></Reference><Reference><Citation>Beyrer K, Dreesman J, Thielen H, Windorfer A. Surveillance-system zur Erfassung zentralnervöser Infektionen in Niedersachsen 1998–2000. [Surveillance system for assessing central nervous Infections in Lower Saxony 1998–2000] Gesundheitswesen. 2002;64:336–343. doi: 10.1055/s-2002-32177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2002-32177</ArticleId><ArticleId IdType="pubmed">12063645</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettenbacher-Riefler S, Beyrer K, Holle I, Monazahian M, Baillot A. MERIN – Meningitis und Enzephalitis Register in Niedersachsen. In: Der Öffentliche Gesundheitsdienst – Jetzt Erst recht! 68. Wissenschaftlicher Kongress Des Bundesverbandes Der Ärztinnen Und Ärzte Des Öffentlichen Gesundheitsdienstes (BVÖGD) Und Des Bundesverbandes Der Zahnärzte Des Öffentlichen Gesundheitsdienstes (BZÖG) in Zusammenarbeit Mit Der Gesellschaft für Hygiene, Umweltmedizin Und Präventivmedizin. 26.04.2018–28.04.2018; Osnabrück. GHUP). Niedersachsen: Georg Thieme Verlag KG; 2018. 10.1055/s-0038-1639252.</Citation></Reference><Reference><Citation>German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines Working Group. MMWR Recomm Rep. 2001;50:1–35.</Citation><ArticleIdList><ArticleId IdType="pubmed">18634202</ArticleId></ArticleIdList></Reference><Reference><Citation>Calba C, Goutard FL, Hoinville L, Hendrikx P, Lindberg A, Saegerman C, Peyre M. Surveillance systems evaluation: a systematic review of the existing approaches. BMC Public Health. 2015;15:448. doi: 10.1186/s12889-015-1791-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-015-1791-5</ArticleId><ArticleId IdType="pmc">PMC4418053</ArticleId><ArticleId IdType="pubmed">25928645</ArticleId></ArticleIdList></Reference><Reference><Citation>Calba C, Goutard FL, Vanholme L, Antoine-Moussiaux N, Hendrikx P, Saegerman C. The added-value of using participatory approaches to assess the acceptability of Surveillance systems: the case of bovine Tuberculosis in Belgium. PLoS ONE. 2016;11:e0159041. doi: 10.1371/journal.pone.0159041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159041</ArticleId><ArticleId IdType="pmc">PMC4962975</ArticleId><ArticleId IdType="pubmed">27462705</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz K, Calba C, Peyre M, Staubach C, Conraths FJ. Hunters’ acceptability of the surveillance system and alternative surveillance strategies for classical swine Fever in wild boar - a participatory approach. BMC Vet Res. 2016;12:187. doi: 10.1186/s12917-016-0822-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-016-0822-5</ArticleId><ArticleId IdType="pmc">PMC5012045</ArticleId><ArticleId IdType="pubmed">27601050</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutard F, Calba C, Chea S, Antoine-Moussiaux N, Pruvot M, Schulz K, Peyre M. The use of participatory methods in the Evaluation of Health Surveillance Systems. In: Peyre M, Roger F, Goutard F, editors. Principles for evaluation of one Health Surveillance: the EVA Book. Cham: Springer International Publishing; 2022. pp. 163–177.</Citation></Reference><Reference><Citation>Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000;283:2680–2685. doi: 10.1001/jama.283.20.2680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.20.2680</ArticleId><ArticleId IdType="pubmed">10819951</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CC, Willis M, Meagher A, Gieseker KE, Rotbart H, Glodé MP. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J. 2002;21:283–286. doi: 10.1097/00006454-200204000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200204000-00005</ArticleId><ArticleId IdType="pubmed">12075757</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, Berginc N, Ladhani S, Susi P, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol. 2018;101:11–17. doi: 10.1016/j.jcv.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer AM, Dobmeier TM, Haglund BJ, Tillgren P. The relevance of WHO injury surveillance guidelines for evaluation: learning from the aboriginal community-centered injury surveillance system (ACCISS) and two institution-based systems. BMC Public Health. 2011;11:744. doi: 10.1186/1471-2458-11-744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-744</ArticleId><ArticleId IdType="pmc">PMC3292514</ArticleId><ArticleId IdType="pubmed">21958054</ArticleId></ArticleIdList></Reference><Reference><Citation>Calba C, Antoine-Moussiaux N, Charrier F, Hendrikx P, Saegerman C, Peyre M, Goutard FL. Applying participatory approaches in the evaluation of surveillance systems: a pilot study on African swine fever surveillance in corsica. Prev Vet Med. 2015;122:389–398. doi: 10.1016/j.prevetmed.2015.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prevetmed.2015.10.001</ArticleId><ArticleId IdType="pubmed">26489602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M-J, Zhao K, Fils-Aime F. Response rates of online surveys in published research: a meta-analysis. Computers in Human Behavior Reports. 2022;7:100206. doi: 10.1016/j.chbr.2022.100206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chbr.2022.100206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter F, Presser S, Tourangeau R. Social Desirability Bias in CATI, IVR, and web surveys: the effects of Mode and question sensitivity. Pub Opin Q. 2008;72:847–865. doi: 10.1093/poq/nfn063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/poq/nfn063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TK, Simmonds P, Harvala H. The importance of enterovirus surveillance in a post-polio world. Lancet Infect Dis. 2022;22:e35–e40. doi: 10.1016/S1473-3099(20)30852-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30852-5</ArticleId><ArticleId IdType="pubmed">34265258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubba L, Broberg EK, Jasir A, Simmonds P, Harvala H. Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study. Lancet Infect Dis. 2020;20:350–361. doi: 10.1016/S1473-3099(19)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30566-3</ArticleId><ArticleId IdType="pubmed">31870905</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Schjørring S, Fischer TK. The importance of enterovirus surveillance in a post-polio world. Clin Microbiol Infect. 2017;23:352–354. doi: 10.1016/j.cmi.2017.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2017.02.010</ArticleId><ArticleId IdType="pubmed">28216324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>